Ysotope Theranostics — Pre-seed · €150K

Ysotope Theranostics, a deeptech spin-off linked to the Vall d'Hebron Research Institute developing radiopharmaceuticals for precision oncology, closed its first investment round of €150,000 with Biozell Ventures — the Valencian life-sciences co-investment vehicle of Biohub VLC led by Ángela Pérez and Fernando Ibáñez — in what was Biozell's debut deal. The company is led by Carlos Langeber, Natalia Benito and Dr. Raúl Herance.